Literature DB >> 30285501

The usefulness of listening social media for pharmacovigilance purposes: a systematic review.

Irma Convertino1, Sara Ferraro1, Corrado Blandizzi1,2, Marco Tuccori1,2.   

Abstract

INTRODUCTION: Social media mining could be a possible strategy to retrieve drug safety information. The mining of social media is a complex process under progressive evolution, falling into three broad categories: listening (safety data reporting), engaging (follow-up), and broadcasting (risk communication). This systematic review is aimed at evaluating the usefulness and quality of proto-signals by social media listening. Areas covered: In this systematic search, performed according to MOOSE and PRISMA statements, we selected studies, published in MEDLINE, EMBASE, and Google Scholar until 31 December 2017, that listened at least one social media to identify proto-adverse drug events and proto-signals. Expert opinion: The selected 38 studies identified serious and unexpected proto-adverse drug events characterized by poorer information quality as compared with spontaneous reporting databases. This feature allows rarely the evaluation of causal relationships. Proto-signals identified by social media listening had the potential of anticipating pre-specified known signals in only six studies. Moreover, the personal perception of patients reported in social media could be used to implement effective risk communication strategies. However, signal detection in social media cannot be currently recommended for routine pharmacovigilance, due to logistic and technical issues.

Entities:  

Keywords:  Social media; pharmacovigilance; proto-signal; signal detection

Mesh:

Year:  2018        PMID: 30285501     DOI: 10.1080/14740338.2018.1531847

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  6 in total

Review 1.  Spontaneously generated online patient experience data - how and why is it being used in health research: an umbrella scoping review.

Authors:  Julia Walsh; Christine Dwumfour; Jonathan Cave; Frances Griffiths
Journal:  BMC Med Res Methodol       Date:  2022-05-14       Impact factor: 4.612

Review 2.  What Can We Learn About Drug Safety and Other Effects in the Era of Electronic Health Records and Big Data That We Would Not Be Able to Learn From Classic Epidemiology?

Authors:  Ali Zarrinpar; Ting-Yuan David Cheng; Zhiguang Huo
Journal:  J Surg Res       Date:  2019-10-22       Impact factor: 2.192

Review 3.  Methods to Establish Race or Ethnicity of Twitter Users: Scoping Review.

Authors:  Su Golder; Robin Stevens; Karen O'Connor; Richard James; Graciela Gonzalez-Hernandez
Journal:  J Med Internet Res       Date:  2022-04-29       Impact factor: 7.076

4.  Social Media Surveillance of Multiple Sclerosis Medications Used During Pregnancy and Breastfeeding: Content Analysis.

Authors:  Bita Rezaallah; David John Lewis; Carrie Pierce; Hans-Florian Zeilhofer; Britt-Isabelle Berg
Journal:  J Med Internet Res       Date:  2019-08-07       Impact factor: 5.428

5.  The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.

Authors:  Marco Tuccori; Irma Convertino; Sara Ferraro; Emiliano Cappello; Giulia Valdiserra; Daniele Focosi; Corrado Blandizzi
Journal:  Drug Saf       Date:  2020-08       Impact factor: 5.228

Review 6.  The Use of Social Media in Detecting Drug Safety-Related New Black Box Warnings, Labeling Changes, or Withdrawals: Scoping Review.

Authors:  Jae-Young Lee; Yae-Seul Lee; Dong Hyun Kim; Han Sol Lee; Bo Ram Yang; Myeong Gyu Kim
Journal:  JMIR Public Health Surveill       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.